CompletedNot Applicable

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

France35 participantsStarted 2024-06-01

Plain-language summary

The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years old, * Tetraplegia or high paraplegia (at or above T4) regardless of the cause, * Non-opposition to the participation to the study, * Having undergone a minimum of 1 session with the Atalante device from February 2019, to now. Exclusion Criteria: * Neurological Level of Injury below T4 as determined by the International Standards for Neurological Classification of SCI

What they're measuring

Safety through the collection of the reported adverse device effects

Timeframe: Baseline, up to 101 weeks.

Trial details

NCT IDNCT06939634

SponsorWandercraft

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Spinal Cord Injury trials